Stage IVB Colorectal Cancer Active Not Recruiting Phase 1 Trials for Durvalumab (DB11714)

IndicationStatusPhase
DBCOND0068497 (Stage IVB Colorectal Cancer)Active Not Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03005002Durvalumab and Tremelimumab in Treating Patients With Microsatellite Stable Metastatic Colorectal Cancer to the LiverTreatment